AzTrials
AzTrials

FrailtyHYPER-FRAILNCT05776394

Study on Hypertension and Frailty in the Older People

An observational study of Frailty and High Blood Pressure, run by Istituto Auxologico Italiano at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To estimate the linear association between daytime systolic blood pressure variability evaluated as standard deviation (SD) and frailty evaluated as Frailty index according to the Rockwood's accumulation of deficits model Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Frailty, High Blood Pressure
How many people
150 participants
Where
1 siteItaly
Study dates
30 May 2022to 31 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • Older adult

Study population: Elderly patients

Who may be able to join

  • Diagnosis of hypertension according to the criteria of the European Society of Cardiology guidelines
  • Consent of the patient (or legal representative) to participate in the study

Who cannot join

  • Refusal of the patient or his/her legal representative
  • Life expectancy of less than 6 months

Trial locations and contacts

1 site in 1 country.

Alessandro IT Croce, MD contact

0261911 ext. 2730

a.croce@auxologico.it

Martino IT Pengo, PhD contact

m.pengo@auxologico.it

Italy1 site, 1 recruiting
  • Ospedale San Luca

    Milan, 28145

    Croce Alessandro, MD, +3961911 ext. 2830, a.croce@auxologico.it

    Recruiting

Other trials in Italy

About this study

Official title: Study on Hypertension and Frailty in the Older People: the HYPER-FRAIL Study

To estimate the linear association between daytime systolic blood pressure variability evaluated as standard deviation (SD) and frailty evaluated as Frailty index according to the Rockwood's accumulation of deficits model

Medical subject headings
Frailty, Hypertension

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Daytime systolic blood pressure variability

    Standard deviation of daytime systolic blood pressure

    Measured: At baseline

Secondary outcomes (2)
  1. Nighttime systolic blood pressure variability

    Standard deviation of nighttime systolic blood pressure

    Measured: At baseline

  2. 24h systolic blood pressure variability

    Standard deviation of 24h systolic blood pressure

    Measured: At baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2023
  2. Study start30 May 2022
  3. Primary completion31 Oct 2023 (estimated)
  4. Study completion31 Oct 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05776394
Sponsor's protocol ID
09C214
Acronym
HYPER-FRAIL
Status last verified
Mar 2023
First submitted
8 Mar 2023
Last updated
20 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Frailty and High Blood Pressure, run by Istituto Auxologico Italiano at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alessandro IT Croce, MD (0261911 ext. 2730, a.croce@auxologico.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Daytime systolic blood pressure variability (time frame: At baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in